And for those who are not day traders, good data over the next month will fill that chart on the upside. Our market cap is a measley 15 million. Incyte have 2 drugs ( baricitnib - RA, ruxolitinib) with postive phase 3 results, market cap 18.9 billion after posting an 18 million loss, so plenty of upside.
Technical Analysis, page-2
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $26.17K | 8.723M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8639698 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 11009899 | 16 |
View Market Depth
| Last trade - 11.24am 14/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |